Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy.
Fujii H, Ueda Y, Hirose C, Ohata K, Sekiya K, Kitahora M, Sadaka S, Yamamoto S, Watanabe D, Kato-Hayashi H, Iihara H, Kobayashi R, Kaburaki M, Matsuhashi N, Takahashi T, Makiyama A, Yoshida K, Hayashi H, Suzuki A. Fujii H, et al. Among authors: sadaka s. J Pharm Health Care Sci. 2022 Mar 2;8(1):8. doi: 10.1186/s40780-022-00239-w. J Pharm Health Care Sci. 2022. PMID: 35236407 Free PMC article.
Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy - a retrospective observational study.
Fujii H, Koda M, Sadaka S, Ohata K, Kato-Hayashi H, Iihara H, Kobayashi R, Ishihara T, Uemura S, Iwashita T, Hayashi H, Sugiyama T, Shimizu M, Suzuki A. Fujii H, et al. Among authors: sadaka s. J Pharm Health Care Sci. 2021 Aug 2;7(1):27. doi: 10.1186/s40780-021-00210-1. J Pharm Health Care Sci. 2021. PMID: 34334136 Free PMC article.
Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced Gastric Cancer.
Fujii H, Sadaka S, Ajisawa K, Okumura N, Makiyama A, Iihara H, Yasufuku I, Ohata K, Kobayashi R, Tanaka Y, Hayashi H, Suzuki A. Fujii H, et al. Among authors: sadaka s. Anticancer Res. 2022 Sep;42(9):4581-4588. doi: 10.21873/anticanres.15961. Anticancer Res. 2022. PMID: 36039452
Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy.
Matsuoka S, Fujii H, Iihara H, Ohata K, Hirose C, Watanabe D, Sadaka S, Kiyama S, Makiyama A, Takahashi T, Kobayashi R, Matsuhashi N, Suzuki A. Matsuoka S, et al. Among authors: sadaka s. Anticancer Res. 2023 May;43(5):2351-2357. doi: 10.21873/anticanres.16400. Anticancer Res. 2023. PMID: 37097664